News

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.
Newly FDA-approved HIV prevention drug, Yeztugo, offers protection for six months—yet the need for a vaccine remains, say ...
The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...
Groundbreaking twice-a-year HIV drug that could stop transmission approved - It's unclear how many people in the US and ...
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...